Keep Me Logged In
Dan Junius, ImmunoGen CEO, discusses which drugs are in the company's pipeline, and weighs in on the outlook for the company, with Mad Money's Jim Cramer.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by